HOLOGIC INC (HOLX)

US4364401012 - Common Stock

73.78  +1.2 (+1.65%)

After market: 73.78 0 (0%)

News Image
a day ago - Zacks Investment Research

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

News Image
3 days ago - Zacks Investment Research

Wall Street Analysts Think Hologic (HOLX) Is a Good Investment: Is It?

Based on the average brokerage recommendation (ABR), Hologic (HOLX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

News Image
4 days ago - Market News Video

Hologic Enters Oversold Territory (HOLX)

News Image
19 days ago - Zacks Investment Research

Hologic (HOLX) Is Considered a Good Investment by Brokers: Is That True?

Based on the average brokerage recommendation (ABR), Hologic (HOLX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

News Image
24 days ago - Zacks Investment Research

Is High Tide (HITI) Stock Outpacing Its Medical Peers This Year?

Here is how High Tide Inc. (HITI) and Hologic (HOLX) have performed compared to their sector so far this year.

News Image
25 days ago - Zacks Investment Research

A Dive into Hologic (HOLX) International Revenue Trends and Forecasts

Review Hologic's (HOLX) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

News Image
25 days ago - Zacks Investment Research

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

News Image
a month ago - InvestorPlace

HOLX Stock Earnings: Hologic Beats EPS, Beats Revenue for Q2 2024

HOLX stock results show that Hologic beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

News Image
a month ago - BusinessInsider

HOLX Stock Earnings: Hologic Beats EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Hologic (NASDAQ:HOLX) just reported results for the second quarter of 2024.Holo...

News Image
a month ago - Zacks Investment Research

How You Should Play Hologic (HOLX) Ahead of Q2 Earnings

Hologic's (HOLX) second-quarter 2024 earnings will likely reflect gains from the GYN surgical business and the growing adoption of Panther instruments.

News Image
a month ago - Zacks Investment Research

Stay Ahead of the Game With Hologic (HOLX) Q2 Earnings: Wall Street's Insights on Key Metrics

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Hologic (HOLX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.

News Image
a month ago - Zacks Investment Research

The Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp

10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp are included in this Analyst Blog.

News Image
a month ago - Zacks Investment Research

Hologic (HOLX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Hologic (HOLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News Image
a month ago - Zacks Investment Research

Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note

Hologic (HOLX) reachead $75.36 at the closing of the latest trading day, reflecting a -0.03% change compared to its last close.

News Image
a month ago - Yahoo Finance

This CEO has battled billionaire activist Carl Icahn twice — here's his advice to Disney CEO Bob Iger

Illumina chairman and Hologic CEO Stephen MacMillan is no stranger to dealing with well-known activist investors.

News Image
a month ago - Zacks Investment Research

Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth

Hologic's (HOLX) second-quarter fiscal 2024 performance is likely to be driven by the GYN Surgical portfolio.

News Image
2 months ago - FinancialNewsMedia

Biotech Innovations Paving the Way in Breast Cancer Fight

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END

News Image
2 months ago - USA News Group

Biotech Innovations Paving the Way in Breast Cancer Fight

/PRNewswire/ -- USA News Group – The American Cancer Society is projecting 2024 to be the first year ever for the US to have more than 2 million new cases,...

News Image
2 months ago - Zacks Investment Research

Hologic (HOLX) Stock Moves -0.05%: What You Should Know

Hologic (HOLX) reachead $76.08 at the closing of the latest trading day, reflecting a -0.05% change compared to its last close.

News Image
2 months ago - Zacks Investment Research

Hologic (HOLX) Ascends While Market Falls: Some Facts to Note

Hologic (HOLX) closed at $75.65 in the latest trading session, marking a +0.52% move from the prior day.